Free Stock Screener
Load Save Create a watchlist HelpQuarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 Dec 2019 | 29 Sep 2019 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $1.664 | $3.365 | |||
Short term investments | $0.651 | $0.651 | |||
Net receivables | $79.202 | $52.535 | |||
Inventory | $9.008 | $8.87 | |||
Other current assets | $33.877 | $45.013 | |||
Total current assets | $125.489 | $111.293 | |||
Long term investments | |||||
Property, plant & equipment | $1,681.694 | $1,720.218 | |||
Goodwill | |||||
Intangible assets | |||||
Other assets | $8.093 | $15.047 | |||
Deferred long term asset charges | |||||
Total assets | $1,815.276 | $1,846.558 | |||
Current liabilities | |||||
Accounts payable | $13.57 | $19.323 | |||
Short long term debt | $2,150.21 | $9.75 | |||
Other current liabilities | $22.348 | $21.252 | |||
Total current liabilities | $2,324.221 | $209.139 | |||
Long term debt | $2,147.287 | ||||
Other liabilities | $228.282 | $223.297 | |||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $2,660.09 | $2,690.356 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $2,140.52 | $2,140.228 | |||
Retained earnings | -$2,985.285 | -$2,983.977 | |||
Treasury stock | -$0.049 | -$0.049 | |||
Capital surplus | |||||
Other stockholder equity | |||||
Total stockholder equity | -$844.814 | -$843.798 | |||
Net tangible assets | -$844.814 | -$843.798 |
(in millions USD) | 2019 | 2018 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $1.664 | $17.014 | ||
Short term investments | $0.651 | $0.651 | ||
Net receivables | $79.202 | $150.821 | ||
Inventory | $9.008 | $18.757 | ||
Other current assets | $33.877 | $25.665 | ||
Total current assets | $125.489 | $214.73 | ||
Long term investments | ||||
Property, plant & equipment | $1,681.694 | $1,509.362 | ||
Goodwill | ||||
Intangible assets | ||||
Other assets | $8.093 | $9.196 | ||
Deferred long term asset charges | ||||
Total assets | $1,815.276 | $1,733.288 | ||
Current liabilities | ||||
Accounts payable | $13.57 | $36.923 | ||
Short long term debt | $2,150.21 | $7.313 | ||
Other current liabilities | $22.348 | $77.364 | ||
Total current liabilities | $2,324.221 | $267.211 | ||
Long term debt | $2,208.168 | |||
Other liabilities | $228.282 | $306.531 | ||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $2,660.09 | $2,781.91 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $2,140.52 | $2,137.443 | ||
Retained earnings | -$2,985.285 | -$3,186.016 | ||
Treasury stock | -$0.049 | -$0.049 | ||
Capital surplus | ||||
Other stockholder equity | ||||
Total stockholder equity | -$844.814 | -$1,048.622 | ||
Net tangible assets | -$844.814 | -$1,048.622 |
Income statement
(in millions USD) | 30 Dec 2019 | 29 Sep 2019 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $152.814 | $129.512 | |||
Cost of revenue | $46.812 | $45.241 | |||
Gross profit | $106.002 | $84.271 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $11.111 | $13.235 | |||
Non-recurring | |||||
Other operating expenses | $15.219 | -$7.102 | |||
Total operating expenses | $120.366 | $100.955 | |||
Operating income | $32.448 | $28.557 | |||
Income from continuing operations | |||||
Net other income | -$34.635 | -$17.044 | |||
EBIT | $32.448 | $28.557 | |||
Interest expense | -$31.324 | -$32.372 | |||
Income before tax | -$2.187 | $11.513 | |||
Income tax expense | -$0.881 | ||||
Minority interest | |||||
Net income from continuing ops | -$1.306 | $11.513 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$1.306 | $11.513 | |||
Income (for common shares) | -$1.306 | $11.513 |
(in millions USD) | 2019 | 2018 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $662.573 | $799.177 | ||
Cost of revenue | $157.865 | $180.096 | ||
Gross profit | $504.708 | $619.081 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $52.019 | $50.952 | ||
Non-recurring | ||||
Other operating expenses | $10.186 | $154.33 | ||
Total operating expenses | $424.297 | $589.633 | ||
Operating income | $238.276 | $209.544 | ||
Income from continuing operations | ||||
Net other income | -$131.338 | -$123.895 | ||
EBIT | $238.276 | $209.544 | ||
Interest expense | -$129.398 | -$148.316 | ||
Income before tax | $106.938 | $85.649 | ||
Income tax expense | -$1.05 | $0.442 | ||
Minority interest | ||||
Net income from continuing ops | $107.988 | $85.207 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | $107.988 | $85.207 | ||
Income (for common shares) | $107.988 | $85.207 |
Cash flows
(in millions USD) | 30 Dec 2019 | 29 Sep 2019 | |||
---|---|---|---|---|---|
Net income | -$1.306 | $11.513 | |||
Operating activities | |||||
Depreciation | $47.224 | $49.581 | |||
Net income adjustments | $14.807 | $8.13 | |||
Change in accounts receivable | -$26.487 | $2.294 | |||
Changes in liabilities | $5.146 | -$11.892 | |||
Changes in inventory | |||||
Changes in other operating activities | -$16.972 | -$0.525 | |||
Total cash flows from operations | $24.934 | $62.357 | |||
Investing activities | |||||
Capital expenditures | -$8.067 | -$56.414 | |||
Investments | |||||
Other cash flows from investing | -$18.265 | -$9.075 | |||
Total cash flows from investing | -$26.323 | -$65.489 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | -$1.738 | $2.563 | |||
Other cash flows from financing | -$0.952 | ||||
Total cash flows from financing | -$1.742 | $1.611 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | -$3.131 | -$1.521 |
(in millions USD) | 2019 | 2018 | ||
---|---|---|---|---|
Net income | $107.988 | $85.207 | ||
Operating activities | ||||
Depreciation | $204.227 | $204.255 | ||
Net income adjustments | -$70.004 | $63.866 | ||
Change in accounts receivable | $62.452 | -$46.276 | ||
Changes in liabilities | -$8.195 | -$13.206 | ||
Changes in inventory | ||||
Changes in other operating activities | -$12.568 | -$1.003 | ||
Total cash flows from operations | $302.416 | $310.897 | ||
Investing activities | ||||
Capital expenditures | -$241.645 | -$438.564 | ||
Investments | ||||
Other cash flows from investing | -$28.516 | -$27.322 | ||
Total cash flows from investing | -$270.152 | -$401.71 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | -$46.613 | $104 | ||
Other cash flows from financing | -$1.44 | -$9.773 | ||
Total cash flows from financing | -$48.128 | $91.849 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -$15.864 | $1.036 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions GBP) | 30 Dec 2020 | 29 Sep 2020 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | £0.738 | £0.738 | |||
Short term investments | |||||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | £0.738 | £0.738 | |||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | £0.738 | £0.738 | |||
Current liabilities | |||||
Accounts payable | £0.026 | £0.026 | |||
Short long term debt | £0.01 | £0.01 | |||
Other current liabilities | |||||
Total current liabilities | £0.116 | £0.116 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | £0.116 | £0.116 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | £1.246 | £1.246 | |||
Retained earnings | -£2.371 | -£2.371 | |||
Treasury stock | £0.003 | £0.003 | |||
Capital surplus | £1.744 | £1.744 | |||
Other stockholder equity | £0.003 | £0.003 | |||
Total stockholder equity | £0.622 | £0.622 | |||
Net tangible assets | £0.622 | £0.622 |
(in millions GBP) | 2020 | 2019 | ||
---|---|---|---|---|
Current assets | ||||
Cash | £0.738 | £1.157 | ||
Short term investments | £0.055741 | |||
Net receivables | £0.042 | |||
Inventory | £0.791 | |||
Other current assets | £0.241259 | |||
Total current assets | £0.738 | £0.003 | ||
Long term investments | £0.352 | |||
Property, plant & equipment | £2.127 | |||
Goodwill | ||||
Intangible assets | ||||
Other assets | £1.848 | |||
Deferred long term asset charges | ||||
Total assets | £0.738 | £0.355 | ||
Current liabilities | ||||
Accounts payable | £0.026 | £0.057 | ||
Short long term debt | £0.01 | £0.01 | ||
Other current liabilities | £0.578 | |||
Total current liabilities | £0.116 | £0.665 | ||
Long term debt | £3.046 | |||
Other liabilities | £0.015 | |||
Deferred long term liabilities | ||||
Minority interest | £0.203 | |||
Total liabilities | £0.116 | £0.665 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | £1.246 | £0.225 | ||
Retained earnings | -£2.371 | -£2.653 | ||
Treasury stock | £0.003 | £0.374 | ||
Capital surplus | £1.744 | £1.744 | ||
Other stockholder equity | £0.003 | £0.374 | ||
Total stockholder equity | £0.622 | -£0.31 | ||
Net tangible assets | £0.622 | -£0.31 |
Income statement
(in millions GBP) | 30 Dec 2020 | 29 Sep 2020 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | -£0.534187 | -£0.546269 | |||
Cost of revenue | -£0.211402 | -£0.217168 | |||
Gross profit | -£0.322784 | -£0.329101 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | -£0.577991 | -£0.594254 | |||
Non-recurring | |||||
Other operating expenses | £0.101684 | £0.103984 | |||
Total operating expenses | -£0.68771 | -£0.707438 | |||
Operating income | £0.153523 | £0.161168 | |||
Income from continuing operations | |||||
Net other income | £0.180506 | £0.181434 | |||
EBIT | £0.153523 | £0.161168 | |||
Interest expense | |||||
Income before tax | £0.334029 | £0.342602 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | £0.334029 | £0.342602 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | £0.306322 | £0.314269 | |||
Income (for common shares) | £0.306322 | £0.314269 |
(in millions GBP) | 2020 | 2019 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | £6.67 | |||
Cost of revenue | £0.087 | £0.032 | ||
Gross profit | -£0.087 | -£0.032 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | £0.282 | £1.64 | ||
Non-recurring | ||||
Other operating expenses | £0.798 | |||
Total operating expenses | £0.369 | £1.672 | ||
Operating income | -£0.369 | -£1.672 | ||
Income from continuing operations | ||||
Net other income | £0.279 | £0.151 | ||
EBIT | -£0.369 | -£1.672 | ||
Interest expense | -£0.305 | |||
Income before tax | -£0.09 | -£1.672 | ||
Income tax expense | ||||
Minority interest | £0.203 | |||
Net income from continuing ops | -£0.09 | -£1.672 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -£0.09 | -£1.672 | ||
Income (for common shares) | -£0.09 | -£1.672 |
Cash flows
(in millions GBP) | 30 Dec 2020 | 29 Sep 2020 | |||
---|---|---|---|---|---|
Net income | £0.306322 | £0.314269 | |||
Operating activities | |||||
Depreciation | -£0.148785 | -£0.152151 | |||
Net income adjustments | -£0.180506 | -£0.181434 | |||
Change in accounts receivable | £0.031977 | £0.032667 | |||
Changes in liabilities | -£0.011726 | -£0.013167 | |||
Changes in inventory | -£0.054305 | -£0.055534 | |||
Changes in other operating activities | £0.008312 | £0.0085 | |||
Total cash flows from operations | -£0.011211 | -£0.00935 | |||
Investing activities | |||||
Capital expenditures | £0.20974 | £0.214484 | |||
Investments | |||||
Other cash flows from investing | -£0.000277 | -£0.000283 | |||
Total cash flows from investing | £0.107502 | £0.109934 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | £0.001385 | £0.001417 | |||
Other cash flows from financing | £0.097251 | £0.099451 | |||
Total cash flows from financing | £0.561136 | £0.563367 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | £0.657428 | £0.663952 |
(in millions GBP) | 2020 | 2019 | ||
---|---|---|---|---|
Net income | -£0.09 | -£1.672 | ||
Operating activities | ||||
Depreciation | £0.98 | |||
Net income adjustments | -£0.279 | £1.537 | ||
Change in accounts receivable | £0.003 | £0.002 | ||
Changes in liabilities | £0.104 | £0.133 | ||
Changes in inventory | £0.016 | |||
Changes in other operating activities | ||||
Total cash flows from operations | -£0.187 | -£0.187 | ||
Investing activities | ||||
Capital expenditures | -£0.007 | |||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | -£0.007 | |||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | -£0.252 | |||
Other cash flows from financing | -£0.178 | |||
Total cash flows from financing | £0.925 | -£0.43 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | £0.738 | -£0.059 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 Mar 2012 | 30 Dec 2011 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.027 | $0.048 | |||
Short term investments | |||||
Net receivables | |||||
Inventory | $0.314 | $0.321 | |||
Other current assets | |||||
Total current assets | $0.341 | $0.369 | |||
Long term investments | |||||
Property, plant & equipment | $0.093 | $0.074 | |||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | $0.434 | $0.443 | |||
Current liabilities | |||||
Accounts payable | |||||
Short long term debt | |||||
Other current liabilities | |||||
Total current liabilities | |||||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | |||||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | |||||
Retained earnings | |||||
Treasury stock | $0.434 | $0.443 | |||
Capital surplus | |||||
Other stockholder equity | $0.434 | $0.443 | |||
Total stockholder equity | $0.434 | $0.443 | |||
Net tangible assets | $0.434 | $0.443 |
(in millions USD) | |
---|---|
Current assets | |
Cash | |
Short term investments | |
Net receivables | |
Inventory | |
Other current assets | |
Total current assets | |
Long term investments | |
Property, plant & equipment | |
Goodwill | |
Intangible assets | |
Other assets | |
Deferred long term asset charges | |
Total assets | |
Current liabilities | |
Accounts payable | |
Short long term debt | |
Other current liabilities | |
Total current liabilities | |
Long term debt | |
Other liabilities | |
Deferred long term liabilities | |
Minority interest | |
Total liabilities | |
Stockholders' equity | |
Stock option warrants | |
Common stock | |
Retained earnings | |
Treasury stock | |
Capital surplus | |
Other stockholder equity | |
Total stockholder equity | |
Net tangible assets |
Income statement
(in millions USD) | 30 Mar 2012 | 30 Dec 2011 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $0.003 | $0.004 | |||
Cost of revenue | $0.036 | $0.041 | |||
Gross profit | -$0.033 | -$0.037 | |||
Operating activities | |||||
Research & development | $0.022 | $0.017 | |||
Selling, general & administrative | $0.014 | $0.02 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $0.072 | $0.078 | |||
Operating income | -$0.069 | -$0.074 | |||
Income from continuing operations | |||||
Net other income | $0.036 | $0.037 | |||
EBIT | -$0.069 | -$0.074 | |||
Interest expense | |||||
Income before tax | -$0.033 | -$0.037 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -$0.033 | -$0.037 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$0.033 | -$0.037 | |||
Income (for common shares) | -$0.033 | -$0.037 |
(in millions USD) | |
---|---|
Revenue | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating activities | |
Research & development | |
Selling, general & administrative | |
Non-recurring | |
Other operating expenses | |
Total operating expenses | |
Operating income | |
Income from continuing operations | |
Net other income | |
EBIT | |
Interest expense | |
Income before tax | |
Income tax expense | |
Minority interest | |
Net income from continuing ops | |
Non-recurring events | |
Discontinued operations | |
Extraordinary items | |
Effect of accounting change | |
Other items | |
Net income | |
Net income | |
Income (for common shares) |
Cash flows
(in millions USD) | 30 Mar 2012 | 30 Dec 2011 | |||
---|---|---|---|---|---|
Net income | -$0.033 | -$0.037 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | |||||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | |||||
Other cash flows from financing | |||||
Total cash flows from financing | |||||
Effect of exchange rate | |||||
Change in cash and equivalents |
(in millions USD) | |
---|---|
Net income | |
Operating activities | |
Depreciation | |
Net income adjustments | |
Change in accounts receivable | |
Changes in liabilities | |
Changes in inventory | |
Changes in other operating activities | |
Total cash flows from operations | |
Investing activities | |
Capital expenditures | |
Investments | |
Other cash flows from investing | |
Total cash flows from investing | |
Financing activities | |
Dividends paid | |
Sale and purchase of stock | |
Net borrowings | |
Other cash flows from financing | |
Total cash flows from financing | |
Effect of exchange rate | |
Change in cash and equivalents |
Profit margin
Debt to assets
Balance sheet
(in millions CNY) | 31 Dec 2019 | 30 Jun 2019 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | ¥48.31 | ¥42.2 | |||
Short term investments | ¥15 | ¥49.15 | |||
Net receivables | ¥641.98 | ¥464.83 | |||
Inventory | ¥383 | ¥487.53 | |||
Other current assets | ¥25.58 | ¥68.79 | |||
Total current assets | ¥1,154.53 | ¥1,174.07 | |||
Long term investments | ¥346.7 | ¥1,430.03 | |||
Property, plant & equipment | ¥159.39 | ¥366.7 | |||
Goodwill | ¥2.13 | ||||
Intangible assets | ¥6.84 | ¥7.12 | |||
Other assets | ¥3.41 | ¥22.59 | |||
Deferred long term asset charges | |||||
Total assets | ¥1,670.87 | ¥3,002.65 | |||
Current liabilities | |||||
Accounts payable | ¥782.32 | ¥61.63 | |||
Short long term debt | ¥655.7 | ¥446.35 | |||
Other current liabilities | ¥581.2 | ¥1,234.23 | |||
Total current liabilities | ¥2,019.22 | ¥1,751.26 | |||
Long term debt | ¥546.77 | ||||
Other liabilities | ¥58.43 | ||||
Deferred long term liabilities | |||||
Minority interest | ¥9.33 | ¥31.12 | |||
Total liabilities | ¥2,106.23 | ¥2,621.61 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | ¥3.96 | ¥3.96 | |||
Retained earnings | -¥439.32 | ¥377.08 | |||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | |||||
Total stockholder equity | -¥435.36 | ¥381.04 | |||
Net tangible assets |
(in millions CNY) | 2019 | 2018 | ||
---|---|---|---|---|
Current assets | ||||
Cash | ¥48.31 | ¥114.8 | ||
Short term investments | ¥15 | ¥69.05 | ||
Net receivables | ¥641.98 | ¥289.03 | ||
Inventory | ¥383 | ¥518.32 | ||
Other current assets | ¥25.58 | ¥74.76 | ||
Total current assets | ¥1,154.53 | ¥1,124.29 | ||
Long term investments | ¥346.7 | ¥867.04 | ||
Property, plant & equipment | ¥159.39 | ¥167.24 | ||
Goodwill | ¥2.13 | |||
Intangible assets | ¥6.84 | ¥4.91 | ||
Other assets | ¥3.41 | ¥15.36 | ||
Deferred long term asset charges | ||||
Total assets | ¥1,670.87 | ¥2,180.97 | ||
Current liabilities | ||||
Accounts payable | ¥782.32 | ¥55.09 | ||
Short long term debt | ¥655.7 | ¥315.49 | ||
Other current liabilities | ¥581.2 | ¥1,130.4 | ||
Total current liabilities | ¥2,019.22 | ¥1,513.33 | ||
Long term debt | ¥298.68 | |||
Other liabilities | ¥65.34 | |||
Deferred long term liabilities | ||||
Minority interest | ¥9.33 | ¥7.85 | ||
Total liabilities | ¥2,106.23 | ¥2,029.35 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | ¥3.96 | ¥3.96 | ||
Retained earnings | -¥439.32 | ¥56.1 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | ||||
Total stockholder equity | -¥435.36 | ¥151.61 | ||
Net tangible assets |
Income statement
(in millions CNY) | 31 Dec 2019 | 30 Jun 2019 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | ¥355.13 | ¥258.05 | |||
Cost of revenue | ¥190.88 | ¥94.14 | |||
Gross profit | ¥164.25 | ¥163.9 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | ¥161.31 | ¥84.02 | |||
Non-recurring | |||||
Other operating expenses | ¥44.12 | ¥65.41 | |||
Total operating expenses | ¥793.13 | ¥328.77 | |||
Operating income | -¥438 | -¥70.73 | |||
Income from continuing operations | |||||
Net other income | ¥44.12 | ¥65.41 | |||
EBIT | |||||
Interest expense | ¥62.43 | ¥48.94 | |||
Income before tax | -¥501.31 | -¥124.47 | |||
Income tax expense | -¥21.54 | -¥23.32 | |||
Minority interest | -¥2.44 | ¥0.27 | |||
Net income from continuing ops | |||||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -¥482.21 | -¥100.89 | |||
Income (for common shares) | -¥482.21 | -¥100.89 |
(in millions CNY) | 2019 | 2018 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | ¥613.18 | ¥773.34 | ||
Cost of revenue | ¥285.02 | ¥419.79 | ||
Gross profit | ¥328.16 | ¥353.54 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ¥245.33 | ¥285.38 | ||
Non-recurring | ||||
Other operating expenses | ¥118.39 | ¥105.88 | ||
Total operating expenses | ¥1,121.91 | ¥825 | ||
Operating income | -¥508.73 | -¥51.67 | ||
Income from continuing operations | ||||
Net other income | ¥118.39 | ¥105.88 | ||
EBIT | ||||
Interest expense | ¥110.37 | -¥36.73 | ||
Income before tax | -¥625.78 | -¥102.94 | ||
Income tax expense | -¥44.85 | ¥12.24 | ||
Minority interest | -¥2.17 | -¥2.21 | ||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -¥583.1 | -¥117.39 | ||
Income (for common shares) | -¥583.1 | -¥117.39 |
Cash flows
(in millions CNY) | |
---|---|
Net income | |
Operating activities | |
Depreciation | |
Net income adjustments | |
Change in accounts receivable | |
Changes in liabilities | |
Changes in inventory | |
Changes in other operating activities | |
Total cash flows from operations | |
Investing activities | |
Capital expenditures | |
Investments | |
Other cash flows from investing | |
Total cash flows from investing | |
Financing activities | |
Dividends paid | |
Sale and purchase of stock | |
Net borrowings | |
Other cash flows from financing | |
Total cash flows from financing | |
Effect of exchange rate | |
Change in cash and equivalents |
(in millions CNY) | 2018 | 2017 | ||
---|---|---|---|---|
Net income | -¥102.94 | ¥2.95 | ||
Operating activities | ||||
Depreciation | ¥24.46 | ¥27.48 | ||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | ¥151.66 | ¥191.33 | ||
Investing activities | ||||
Capital expenditures | -¥9.5 | -¥26.2 | ||
Investments | ||||
Other cash flows from investing | -¥42.03 | -¥160.55 | ||
Total cash flows from investing | -¥51.53 | -¥186.75 | ||
Financing activities | ||||
Dividends paid | -¥32.44 | |||
Sale and purchase of stock | ||||
Net borrowings | -¥122.99 | ¥54.38 | ||
Other cash flows from financing | ¥46.64 | -¥74.9 | ||
Total cash flows from financing | -¥76.35 | -¥52.96 | ||
Effect of exchange rate | ¥0.38 | -¥1.13 | ||
Change in cash and equivalents | ¥24.16 | -¥49.52 |
OCSMD
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 May 2010 | 27 Feb 2010 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.009521 | $0.024609 | |||
Short term investments | |||||
Net receivables | $0.150126 | $0.233199 | |||
Inventory | $0.790674 | $0.732336 | |||
Other current assets | $0.063823 | $0.08339 | |||
Total current assets | $1.014144 | $1.073534 | |||
Long term investments | |||||
Property, plant & equipment | $3.069608 | $3.183786 | |||
Goodwill | |||||
Intangible assets | |||||
Other assets | $0.733341 | $0.810811 | |||
Deferred long term asset charges | |||||
Total assets | $4.817093 | $5.068131 | |||
Current liabilities | |||||
Accounts payable | $1.186043 | $1.123059 | |||
Short long term debt | $0.511157 | $0.51402 | |||
Other current liabilities | |||||
Total current liabilities | $1.935452 | $1.87778 | |||
Long term debt | $0.61964 | $0.62123 | |||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $2.555092 | $2.49901 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.002636 | $0.002637 | |||
Retained earnings | -$26.230756 | -$25.920695 | |||
Treasury stock | -$0.230591 | -$0.228169 | |||
Capital surplus | $28.711885 | $28.706521 | |||
Other stockholder equity | -$0.230591 | -$0.228169 | |||
Total stockholder equity | $2.253174 | $2.560294 | |||
Net tangible assets | $2.253174 | $2.560294 |
(in millions USD) | 2009 | 2008 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.012356 | $0.712298 | ||
Short term investments | ||||
Net receivables | $0.233376 | $0.195402 | ||
Inventory | $0.553311 | $1.290702 | ||
Other current assets | $0.052056 | $0.080011 | ||
Total current assets | $0.851099 | $2.278413 | ||
Long term investments | ||||
Property, plant & equipment | $3.350709 | $3.982336 | ||
Goodwill | ||||
Intangible assets | ||||
Other assets | $1.084798 | $1.104164 | ||
Deferred long term asset charges | ||||
Total assets | $5.286606 | $7.364913 | ||
Current liabilities | ||||
Accounts payable | $0.904661 | $0.862704 | ||
Short long term debt | $0.498621 | $0.49195 | ||
Other current liabilities | ||||
Total current liabilities | $1.702947 | $1.62236 | ||
Long term debt | $0.598306 | $0.548004 | ||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $2.301253 | $2.170364 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.002592 | $0.002448 | ||
Retained earnings | -$25.00857 | -$22.103314 | ||
Treasury stock | -$0.390136 | -$0.211193 | ||
Capital surplus | $28.37264 | $27.497781 | ||
Other stockholder equity | -$0.390136 | -$0.211193 | ||
Total stockholder equity | $2.976526 | $5.185722 | ||
Net tangible assets | $2.976526 | $5.185722 |
Income statement
(in millions USD) | 30 May 2010 | 27 Feb 2010 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $0.536152 | $0.654942 | |||
Cost of revenue | $0.581593 | $0.661506 | |||
Gross profit | -$0.045441 | -$0.006564 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.234238 | $0.298668 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $0.815831 | $0.960174 | |||
Operating income | -$0.279679 | -$0.305232 | |||
Income from continuing operations | |||||
Net other income | -$0.030382 | -$0.017807 | |||
EBIT | -$0.279679 | -$0.305232 | |||
Interest expense | -$0.018013 | -$0.018134 | |||
Income before tax | -$0.310061 | -$0.323039 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -$0.310061 | -$0.323039 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$0.310061 | -$0.323039 | |||
Income (for common shares) | -$0.310061 | -$0.646239 |
(in millions USD) | 2009 | 2008 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $1.890536 | $1.584027 | ||
Cost of revenue | $2.576938 | $2.062758 | ||
Gross profit | -$0.686402 | -$0.478731 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $1.64147 | $3.18546 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $4.218408 | $5.248218 | ||
Operating income | -$2.327872 | -$3.664191 | ||
Income from continuing operations | ||||
Net other income | $0.063019 | -$0.016931 | ||
EBIT | -$2.327872 | -$3.664191 | ||
Interest expense | -$0.057285 | -$0.010993 | ||
Income before tax | -$2.264853 | -$3.681122 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | -$2.264853 | -$3.681122 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -$2.264853 | -$3.681122 | ||
Income (for common shares) | -$2.905256 | -$4.57501 |
Cash flows
(in millions USD) | 30 May 2010 | 27 Feb 2010 | |||
---|---|---|---|---|---|
Net income | -$0.310061 | -$0.323039 | |||
Operating activities | |||||
Depreciation | $0.145462 | $0.141567 | |||
Net income adjustments | $0.015349 | $0.005363 | |||
Change in accounts receivable | $0.073087 | -$0.025601 | |||
Changes in liabilities | $0.077267 | $0.098689 | |||
Changes in inventory | $0.017258 | $0.125345 | |||
Changes in other operating activities | $0.019566 | -$0.036345 | |||
Total cash flows from operations | $0.037928 | -$0.014022 | |||
Investing activities | |||||
Capital expenditures | -$0.004639 | -$0.014995 | |||
Investments | |||||
Other cash flows from investing | $0.000103 | ||||
Total cash flows from investing | -$0.035324 | $0.015793 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | -$0.005792 | -$0.000195 | |||
Other cash flows from financing | |||||
Total cash flows from financing | -$0.005792 | -$0.000195 | |||
Effect of exchange rate | -$0.0119 | $0.005256 | |||
Change in cash and equivalents | -$0.015088 | $0.006832 |
(in millions USD) | 2009 | 2008 | ||
---|---|---|---|---|
Net income | -$2.264853 | -$3.681122 | ||
Operating activities | ||||
Depreciation | $0.570617 | $0.563456 | ||
Net income adjustments | $0.2776 | $1.871482 | ||
Change in accounts receivable | -$0.037974 | -$0.121979 | ||
Changes in liabilities | $0.123447 | $0.269769 | ||
Changes in inventory | $0.472804 | -$0.449516 | ||
Changes in other operating activities | $0.145579 | -$0.050588 | ||
Total cash flows from operations | -$0.71278 | -$1.598498 | ||
Investing activities | ||||
Capital expenditures | -$0.084179 | -$1.592581 | ||
Investments | ||||
Other cash flows from investing | -$0.005672 | -$0.005672 | ||
Total cash flows from investing | -$0.089851 | -$1.592581 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $0.038153 | $0.04667 | ||
Other cash flows from financing | ||||
Total cash flows from financing | $0.038153 | $2.308895 | ||
Effect of exchange rate | $0.064536 | -$0.062386 | ||
Change in cash and equivalents | -$0.699942 | -$0.94457 |